Showing results (501-510 of 585) with videos related to

Sort By:
Pageof 59
Journal of Gastroenterology|January 21, 2022
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosisYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
BMC Medical Genetics|June 21, 2012
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populationsHiromi Sawai, Nao Nishida, Hamdi Mbarek, et al.
JCO Clinical Cancer Informatics|May 12, 2025
Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival BenefitHidenori Toyoda, Atsushi Hiraoka, Hironori Ochi, et al.
Scientific Reports|May 19, 2022
C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinibToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Cancer Medicine|December 9, 2022
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation studyToshifumi Tada, Takashi Kumada, Atsushi Hiraoka, et al.
Cancer Medicine|September 26, 2022
The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC-GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysisTakeshi Hatanaka, Atsushi Naganuma, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 26, 2022
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysisTakeshi Hatanaka, Atsushi Hiraoka, Toshifumi Tada, et al.
Plos One|June 28, 2012
Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and KoreanNao Nishida, Hiromi Sawai, Kentaro Matsuura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 20, 2021
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC-B stage patients classified as beyond up to seven criteria - Multicenter analysisAtsushi Hiraoka, Takashi Kumada, Toshifumi Tada, et al.
Scientific Reports|April 20, 2016
Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysisNao Nishida, Jun Ohashi, Seik-Soon Khor, et al.
Pageof 59